Skip to main content


  1. Parving, H.-H., Harrington, J. T., Lewis, J., Boner, G., Lewis, E. J., Viberti, G., Gilbert, R., Raz, I., Cooper, M., and Rossing, P. (2001) Diabetic nephropathy: prevention and treatment. Kidney Internat. 60, 2041-2055
  2. Stengel, B., Billon, S., van Dijk, P. C. W., Jager, K. J., Dekker, F. W., Simpson, K., and Briggs, J. K. (2003) Trends in the incidence of renal replacement therapy for end-stage renal disease in Europe, 1990-1999. Nephrol.Dialysis Transplant. 18, 1824-1833
  3. Adler, A. I., Stevens, R. J., Manley, S. E., Bilous, R. W., Cull, C. A., Holman, R. R., and UK Prospective Diabetes Study Group (2003) Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Internat. 63, 225-252
  4. The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New Engl.J.Med. 327, 977-986
  5. Stratton, I. M., Adler, A. I., Neil, H. A. W., Matthews, D. R., Manley, S. E., Cull, C. A., Hadden, D., Turner, R. C., and Holman, R. R. (2002) Association of glycaemic with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 321, 405-412
  6. Department of Health, UK Government. (2002) National Service Framework For Diabetes: delivery strategy. 1-40
  7. American Diabetes Association (2003) Position statements: Standards of medical care for patients with diabetes mellitus. Diabetes Care 26, S33-S50
  8. Brownlee, M. (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414, 813-820
  9. Thornalley, P. J., Jahan, I., and Ng, R. (2001) Suppression of the accumulation of triosephosphates and increased formation of methylglyoxal in human red blood cells during hyperglycaemia by thiamine in vitro. Japan.J.Biochem. 129, 543-549
  10. Babaei-Jadidi, R., Karachalias, N., Ahmed, N., Battah, S., and Thornalley, P. J. (2003) Prevention of incipient diabetic nephropathy by high dose thiamine and Benfotiamine. Diabetes 52, 2110-2120
  11. Saito, N., Kimura, M., Kuchiba, A., and Itokawa, Y. (1987) Blood thiamine levels in outpatients with diabetes mellitus. J.Nutr.Sci.Vitaminol. 33, 421-430
  12. Havivi, E., Bar On, H., Reshef, A., and Raz, I. (1991) Vitamins and trace metals status in non insulin dependent diabetes mellitus. Internat.J.Vit.Nutr.Res. 61, 328-333
  13. Valerio, G., Franzese, A., Poggi, V., Patrini, C., Laforenza, U., and Tenore, A. (1999) Lipophilic thiamine treatment in longstanding insulin-dependent diabetes mellitus. Acta Diabetol. 36, 73-76